Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
Phase 1
20
about 1.2 years
21+
Male only
7 sites in IL, LA, MD +4
What this study is about
Researchers are testing whether a treatment called Enolen, which delivers enzalutamide directly into the prostate, is safe and effective for men with prostate cancer who are planning surgery. The trial will involve placing implants containing enzalutamide into the prostate of up to 20 participants. Participants will undergo MRI scans before and after implant placement, as well as follow-up visits to monitor their health and quality of life.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take enzalutamide
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
enzalutamide
oral (Oral Tablet)
Primary: Measurement of Pharmacokinetics Profile, To assess the adverse events associated with the Enolen implant
Secondary: MRI changes